Global Molecular Targeted Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Molecular Targeted Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Molecular-targeted therapy is a novel strategy born from our increasing understanding of the underlying pathways and key molecules involved in tumor growth and progression. Theoretically, the specificity of molecular targeted therapy should improve the therapeutic window by affecting the tumor cells and sparing normal cell.
Molecular Targeted Therapy report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Molecular Targeted Therapy market is projected to reach US$ 261.5 million in 2033, increasing from US$ 139 million in 2022, with the CAGR of 10.2% during the period of 2023 to 2033. Demand from Lung Cancer and Breast Cancer are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Molecular Targeted Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

By Company

Phoenix Molecular Designs
Prelude Therapeutics
Tempus
Bracco
iOmx Therapeutics
OncoDNA
Sapience Therapeutics
Caris Life Sciences
Hera Biolabs
CV6 Therapeutics
Carrick Therapeutics
Foundation Medicine
Cybrexa Therapeutics
Segment by Type
Monoclonal Antibodies
Small Molecule Inhibitors

Segment by Application

Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Molecular Targeted Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Molecular Targeted Therapy introduction, etc. Molecular Targeted Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Molecular Targeted Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Molecular Targeted Therapy
1.1 Molecular Targeted Therapy Market Overview
1.1.1 Molecular Targeted Therapy Product Scope
1.1.2 Molecular Targeted Therapy Market Status and Outlook
1.2 Global Molecular Targeted Therapy Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Molecular Targeted Therapy Market Size by Region (2018-2033)
1.4 Global Molecular Targeted Therapy Historic Market Size by Region (2018-2023)
1.5 Global Molecular Targeted Therapy Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Molecular Targeted Therapy Market Size (2018-2033)
1.6.1 North America Molecular Targeted Therapy Market Size (2018-2033)
1.6.2 Europe Molecular Targeted Therapy Market Size (2018-2033)
1.6.3 Asia-Pacific Molecular Targeted Therapy Market Size (2018-2033)
1.6.4 Latin America Molecular Targeted Therapy Market Size (2018-2033)
1.6.5 Middle East & Africa Molecular Targeted Therapy Market Size (2018-2033)
2 Molecular Targeted Therapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Small Molecule Inhibitors
2.2 Global Molecular Targeted Therapy Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Molecular Targeted Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Molecular Targeted Therapy Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Molecular Targeted Therapy Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Molecular Targeted Therapy Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Molecular Targeted Therapy Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Molecular Targeted Therapy Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Molecular Targeted Therapy Revenue Breakdown by Type (2018-2033)
3 Molecular Targeted Therapy Market Overview by Application
3.1 Introduction
3.1.1 Lung Cancer
3.1.2 Breast Cancer
3.1.3 Colorectal Cancer
3.1.4 Leukemia
3.1.5 Others
3.2 Global Molecular Targeted Therapy Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Molecular Targeted Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Molecular Targeted Therapy Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Molecular Targeted Therapy Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Molecular Targeted Therapy Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Molecular Targeted Therapy Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Molecular Targeted Therapy Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Molecular Targeted Therapy Revenue Breakdown by Application (2018-2033)
4 Molecular Targeted Therapy Competition Analysis by Players
4.1 Global Molecular Targeted Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Targeted Therapy as of 2022)
4.3 Date of Key Players Enter into Molecular Targeted Therapy Market
4.4 Global Top Players Molecular Targeted Therapy Headquarters and Area Served
4.5 Key Players Molecular Targeted Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Molecular Targeted Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Phoenix Molecular Designs
5.1.1 Phoenix Molecular Designs Profile
5.1.2 Phoenix Molecular Designs Main Business
5.1.3 Phoenix Molecular Designs Molecular Targeted Therapy Products, Services and Solutions
5.1.4 Phoenix Molecular Designs Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Phoenix Molecular Designs Recent Developments
5.2 Prelude Therapeutics
5.2.1 Prelude Therapeutics Profile
5.2.2 Prelude Therapeutics Main Business
5.2.3 Prelude Therapeutics Molecular Targeted Therapy Products, Services and Solutions
5.2.4 Prelude Therapeutics Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Prelude Therapeutics Recent Developments
5.3 Tempus
5.3.1 Tempus Profile
5.3.2 Tempus Main Business
5.3.3 Tempus Molecular Targeted Therapy Products, Services and Solutions
5.3.4 Tempus Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Bracco Recent Developments
5.4 Bracco
5.4.1 Bracco Profile
5.4.2 Bracco Main Business
5.4.3 Bracco Molecular Targeted Therapy Products, Services and Solutions
5.4.4 Bracco Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Bracco Recent Developments
5.5 iOmx Therapeutics
5.5.1 iOmx Therapeutics Profile
5.5.2 iOmx Therapeutics Main Business
5.5.3 iOmx Therapeutics Molecular Targeted Therapy Products, Services and Solutions
5.5.4 iOmx Therapeutics Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 iOmx Therapeutics Recent Developments
5.6 OncoDNA
5.6.1 OncoDNA Profile
5.6.2 OncoDNA Main Business
5.6.3 OncoDNA Molecular Targeted Therapy Products, Services and Solutions
5.6.4 OncoDNA Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 OncoDNA Recent Developments
5.7 Sapience Therapeutics
5.7.1 Sapience Therapeutics Profile
5.7.2 Sapience Therapeutics Main Business
5.7.3 Sapience Therapeutics Molecular Targeted Therapy Products, Services and Solutions
5.7.4 Sapience Therapeutics Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Sapience Therapeutics Recent Developments
5.8 Caris Life Sciences
5.8.1 Caris Life Sciences Profile
5.8.2 Caris Life Sciences Main Business
5.8.3 Caris Life Sciences Molecular Targeted Therapy Products, Services and Solutions
5.8.4 Caris Life Sciences Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Caris Life Sciences Recent Developments
5.9 Hera Biolabs
5.9.1 Hera Biolabs Profile
5.9.2 Hera Biolabs Main Business
5.9.3 Hera Biolabs Molecular Targeted Therapy Products, Services and Solutions
5.9.4 Hera Biolabs Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Hera Biolabs Recent Developments
5.10 CV6 Therapeutics
5.10.1 CV6 Therapeutics Profile
5.10.2 CV6 Therapeutics Main Business
5.10.3 CV6 Therapeutics Molecular Targeted Therapy Products, Services and Solutions
5.10.4 CV6 Therapeutics Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 CV6 Therapeutics Recent Developments
5.11 Carrick Therapeutics
5.11.1 Carrick Therapeutics Profile
5.11.2 Carrick Therapeutics Main Business
5.11.3 Carrick Therapeutics Molecular Targeted Therapy Products, Services and Solutions
5.11.4 Carrick Therapeutics Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Carrick Therapeutics Recent Developments
5.12 Foundation Medicine
5.12.1 Foundation Medicine Profile
5.12.2 Foundation Medicine Main Business
5.12.3 Foundation Medicine Molecular Targeted Therapy Products, Services and Solutions
5.12.4 Foundation Medicine Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Foundation Medicine Recent Developments
5.13 Cybrexa Therapeutics
5.13.1 Cybrexa Therapeutics Profile
5.13.2 Cybrexa Therapeutics Main Business
5.13.3 Cybrexa Therapeutics Molecular Targeted Therapy Products, Services and Solutions
5.13.4 Cybrexa Therapeutics Molecular Targeted Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Cybrexa Therapeutics Recent Developments
6 North America
6.1 North America Molecular Targeted Therapy Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Molecular Targeted Therapy Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Molecular Targeted Therapy Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Molecular Targeted Therapy Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Molecular Targeted Therapy Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Molecular Targeted Therapy Market Dynamics
11.1 Molecular Targeted Therapy Industry Trends
11.2 Molecular Targeted Therapy Market Drivers
11.3 Molecular Targeted Therapy Market Challenges
11.4 Molecular Targeted Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Molecular Targeted Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Molecular Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Molecular Targeted Therapy Market Size Share by Region (2018-2023)
Table 4. Global Molecular Targeted Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Molecular Targeted Therapy Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Molecular Targeted Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Molecular Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Molecular Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Molecular Targeted Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Molecular Targeted Therapy Revenue Market Share by Type (2024-2033)
Table 11. North America Molecular Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Molecular Targeted Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Molecular Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Molecular Targeted Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Molecular Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Molecular Targeted Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Molecular Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Molecular Targeted Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Molecular Targeted Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Molecular Targeted Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Molecular Targeted Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Molecular Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Molecular Targeted Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Molecular Targeted Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Molecular Targeted Therapy Revenue Market Share by Application (2024-2033)
Table 26. North America Molecular Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Molecular Targeted Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Molecular Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Molecular Targeted Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Molecular Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Molecular Targeted Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Molecular Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Molecular Targeted Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Molecular Targeted Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Molecular Targeted Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Molecular Targeted Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Molecular Targeted Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Targeted Therapy as of 2022)
Table 39. Date of Key Players Enter into Molecular Targeted Therapy Market
Table 40. Global Molecular Targeted Therapy Key Players Headquarters and Area Served
Table 41. Molecular Targeted Therapy Product Solution and Service
Table 42. Global Molecular Targeted Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Phoenix Molecular Designs Basic Information List
Table 45. Phoenix Molecular Designs Description and Business Overview
Table 46. Phoenix Molecular Designs Molecular Targeted Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Molecular Targeted Therapy Business of Phoenix Molecular Designs (2018-2023)
Table 48. Phoenix Molecular Designs Recent Developments
Table 49. Prelude Therapeutics Basic Information List
Table 50. Prelude Therapeutics Description and Business Overview
Table 51. Prelude Therapeutics Molecular Targeted Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Molecular Targeted Therapy Business of Prelude Therapeutics (2018-2023)
Table 53. Prelude Therapeutics Recent Developments
Table 54. Tempus Basic Information List
Table 55. Tempus Description and Business Overview
Table 56. Tempus Molecular Targeted Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Molecular Targeted Therapy Business of Tempus (2018-2023)
Table 58. Tempus Recent Developments
Table 59. Bracco Basic Information List
Table 60. Bracco Description and Business Overview
Table 61. Bracco Molecular Targeted Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Molecular Targeted Therapy Business of Bracco (2018-2023)
Table 63. Bracco Recent Developments
Table 64. iOmx Therapeutics Basic Information List
Table 65. iOmx Therapeutics Description and Business Overview
Table 66. iOmx Therapeutics Molecular Targeted Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Molecular Targeted Therapy Business of iOmx Therapeutics (2018-2023)
Table 68. iOmx Therapeutics Recent Developments
Table 69. OncoDNA Basic Information List
Table 70. OncoDNA Description and Business Overview
Table 71. OncoDNA Molecular Targeted Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Molecular Targeted Therapy Business of OncoDNA (2018-2023)
Table 73. OncoDNA Recent Developments
Table 74. Sapience Therapeutics Basic Information List
Table 75. Sapience Therapeutics Description and Business Overview
Table 76. Sapience Therapeutics Molecular Targeted Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Molecular Targeted Therapy Business of Sapience Therapeutics (2018-2023)
Table 78. Sapience Therapeutics Recent Developments
Table 79. Caris Life Sciences Basic Information List
Table 80. Caris Life Sciences Description and Business Overview
Table 81. Caris Life Sciences Molecular Targeted Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Molecular Targeted Therapy Business of Caris Life Sciences (2018-2023)
Table 83. Caris Life Sciences Recent Developments
Table 84. Hera Biolabs Basic Information List
Table 85. Hera Biolabs Description and Business Overview
Table 86. Hera Biolabs Molecular Targeted Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Molecular Targeted Therapy Business of Hera Biolabs (2018-2023)
Table 88. Hera Biolabs Recent Developments
Table 89. CV6 Therapeutics Basic Information List
Table 90. CV6 Therapeutics Description and Business Overview
Table 91. CV6 Therapeutics Molecular Targeted Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Molecular Targeted Therapy Business of CV6 Therapeutics (2018-2023)
Table 93. CV6 Therapeutics Recent Developments
Table 94. Carrick Therapeutics Basic Information List
Table 95. Carrick Therapeutics Description and Business Overview
Table 96. Carrick Therapeutics Molecular Targeted Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Molecular Targeted Therapy Business of Carrick Therapeutics (2018-2023)
Table 98. Carrick Therapeutics Recent Developments
Table 99. Foundation Medicine Basic Information List
Table 100. Foundation Medicine Description and Business Overview
Table 101. Foundation Medicine Molecular Targeted Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Molecular Targeted Therapy Business of Foundation Medicine (2018-2023)
Table 103. Foundation Medicine Recent Developments
Table 104. Cybrexa Therapeutics Basic Information List
Table 105. Cybrexa Therapeutics Description and Business Overview
Table 106. Cybrexa Therapeutics Molecular Targeted Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Molecular Targeted Therapy Business of Cybrexa Therapeutics (2018-2023)
Table 108. Cybrexa Therapeutics Recent Developments
Table 109. North America Molecular Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 110. North America Molecular Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 111. Europe Molecular Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 112. Europe Molecular Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 113. Asia-Pacific Molecular Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Asia-Pacific Molecular Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 115. Asia-Pacific Molecular Targeted Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 116. Asia-Pacific Molecular Targeted Therapy Market Share by Region (2018-2023)
Table 117. Asia-Pacific Molecular Targeted Therapy Market Share by Region (2024-2033)
Table 118. Latin America Molecular Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 119. Latin America Molecular Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 120. Latin America Molecular Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 121. Middle East & Africa Molecular Targeted Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 122. Middle East & Africa Molecular Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 123. Middle East & Africa Molecular Targeted Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 124. Molecular Targeted Therapy Market Trends
Table 125. Molecular Targeted Therapy Market Drivers
Table 126. Molecular Targeted Therapy Market Challenges
Table 127. Molecular Targeted Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Targeted Therapy Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Molecular Targeted Therapy Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Molecular Targeted Therapy Market Share by Regions: 2022 VS 2033
Figure 4. Global Molecular Targeted Therapy Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Molecular Targeted Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Molecular Targeted Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Molecular Targeted Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Molecular Targeted Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Molecular Targeted Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Small Molecule Inhibitors
Figure 13. Global Small Molecule Inhibitors Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Molecular Targeted Therapy Market Size Share by Type: 2022 & 2033
Figure 15. North America Molecular Targeted Therapy Revenue Market Share by Type (2018-2033)
Figure 16. Europe Molecular Targeted Therapy Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Molecular Targeted Therapy Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Molecular Targeted Therapy Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Molecular Targeted Therapy Revenue Market Share by Type (2018-2033)
Figure 20. Lung Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Breast Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Leukemia Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Global Molecular Targeted Therapy Market Size Share by Application: 2022 & 2033
Figure 26. North America Molecular Targeted Therapy Revenue Market Share by Application (2018-2033)
Figure 27. Europe Molecular Targeted Therapy Revenue Market Share by Application (2018-2033)
Figure 28. Asia-Pacific Molecular Targeted Therapy Revenue Market Share by Application (2018-2033)
Figure 29. Latin America Molecular Targeted Therapy Revenue Market Share by Application (2018-2033)
Figure 30. Middle East and Africa Molecular Targeted Therapy Revenue Market Share by Application (2018-2033)
Figure 31. Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Molecular Targeted Therapy Market Share in 2022
Figure 33. North America Molecular Targeted Therapy Market Share by Country (2018-2033)
Figure 34. United States Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 35. Canada Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 36. Germany Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 37. France Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 38. U.K. Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 39. Italy Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 40. Russia Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 41. Nordic Countries Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Molecular Targeted Therapy Market Share by Region (2018-2033)
Figure 43. China Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 44. Japan Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 45. South Korea Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 47. India Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 48. Australia Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 49. Latin America Molecular Targeted Therapy Market Share by Country (2018-2033)
Figure 50. Mexico Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 51. Brazil Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Molecular Targeted Therapy Market Share by Country (2018-2033)
Figure 53. Turkey Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 55. UAE Molecular Targeted Therapy Market Size (2018-2033) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Global Molecular Targeted Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Global Molecular Targeted Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

By Company

Segment by Application

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries